CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.
- DOI
- 10.1016/j.ijid.2020.10.101
- Published
- 2021 Feb
- Container
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijid.2020.10.101,
title = {CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.},
author = {Patterson BK and Seethamraju H and Dhody K and Corley MJ and Kazempour K and Lalezari J and Pang APS and Sugai C and Mahyari E and Francisco EB and Pise A and Rodrigues H and Wu HL and Webb GM and Park BS and Kelly S and Pourhassan N and Lelic A and Kdouh L and Herrera M and Hall E and Bimber BN and Plassmeyer M and Gupta R and Alpan O and O'Halloran JA and Mudd PA and Akalin E and Ndhlovu LC and Sacha JB},
year = {2021},
journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
doi = {10.1016/j.ijid.2020.10.101},
url = {https://doi.org/10.1016/j.ijid.2020.10.101}
}RIS
TY - JOUR TI - CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. AU - Patterson BK AU - Seethamraju H AU - Dhody K AU - Corley MJ AU - Kazempour K AU - Lalezari J AU - Pang APS AU - Sugai C AU - Mahyari E AU - Francisco EB AU - Pise A AU - Rodrigues H AU - Wu HL AU - Webb GM AU - Park BS AU - Kelly S AU - Pourhassan N AU - Lelic A AU - Kdouh L AU - Herrera M AU - Hall E AU - Bimber BN AU - Plassmeyer M AU - Gupta R AU - Alpan O AU - O'Halloran JA AU - Mudd PA AU - Akalin E AU - Ndhlovu LC AU - Sacha JB PY - 2021 JO - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases DO - 10.1016/j.ijid.2020.10.101 UR - https://doi.org/10.1016/j.ijid.2020.10.101 ER -
APA
BK, P., H, S., K, D., MJ, C., K, K., J, L., APS, P., C, S., E, M., EB, F., A, P., H, R., HL, W., GM, W., BS, P., S, K., N, P., A, L., L, K., M, H., E, H., BN, B., M, P., R, G., O, A., JA, O., PA, M., E, A., LC, N., & JB, S. (2021). CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2020.10.101
Source records
- pubmed · retrieved 2026-09-26T11:00:31.053Z